Ropeginterferon Alfa-2b Response Improves With NFKB1 Haplotype in PV and ET
Response to ropeginterferon alfa-2b (Besremi) was improved with the presence of the NFKB1 rs230511 haplotype among patients with polycythemia vera (PV) and essential thrombocythemia (ET), according to findings from a study presented during the 2024 ASH …